Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-02-23

FDA Approved: THIORIDAZINE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approved a supplemental application for thioridazine hydrochloride (Chartwell RX, LLC), authorizing continued marketing of this antipsychotic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Thioridazine hydrochloride (thioridazine hydrochloride)

Snippet

SUPPL AP for THIORIDAZINE HYDROCHLORIDE (THIORIDAZINE HYDROCHLORIDE)